Cancer is now the most common chronic diseases in developed countries worldwide. In Ireland alone, excluding non-melanoma skin cancer, it is estimated that by 2040 cancer cases will increase by 81% for females and 108% for males. In addition, Ireland is following the global trend towards an ageing demographic that will result in a corresponding increase in the incidence of cancer.
There are increasing opportunities to improve our approach to cancer prevention. It is now possible for some patients to identify the best approach to cancer treatment based on the genetic profile of their tumour. Fully characterizing a person’s genetic makeup and understanding their environmental exposures over time will enable us to tailor personalised measures to screen for and prevent cancer.
Our research programmes in cancer prevention are focused on:
The Cancer Prevention Research Theme within the Trinity St James Cancer Institute comprises a broad spectrum of research areas, from molecular epidemiology, molecular diagnostics, cancer, genetics, translational research, cancer screening, disease modelling, behavioural science, and medical gerontology. We have several well-established research consortium, working in the area of cancer prevention of ageing population www.tilda.tcd.ie and the cervical screening population www.cerviva.ie
Theme Leads